Over the last 45 years, I have been working on growth factors, their receptors and signal transduction mechanisms. This period has seen a tremendous growth in knowledge and technology, and all of this, together with a focus interest in oncology, has steered me along a path designed to understand growth factor signalling so that we can see how drugs that target signalling pathways might be able to control cancer. The knowledge that we already have is likely to lead to cures for many common cancers within the next 25 years.
Discussion| January 22 2007
Cracking the mild, difficult and fiendish codes within and downstream of the EGFR to link diagnostics and therapeutics
- Views Icon Views
- Share Icon Share
- Cite Icon Cite
M. Waterfield; Cracking the mild, difficult and fiendish codes within and downstream of the EGFR to link diagnostics and therapeutics. Biochem Soc Trans 1 February 2007; 35 (1): 1–6. doi: https://doi.org/10.1042/BST0350001
Download citation file: